Analyst firms · Raymond James · DYN
Raymond James DYN price target and rating history
Dyne Therapeutics Inc. (DYN) · Health Care
Raymond James rates Dyne Therapeutics Inc. (DYN) Strong Buy with a $35 price target, as of its latest action on Aug 25, 2025. It has published 4 rating actions on DYN since July 2022, including 2 upgrades and 0 downgrades.
- Current rating
- Strong Buy
- Price target
- $35
- Median target, all firms
- Too few
- Actions on DYN
- 4
Raymond James price target on DYN
Every Raymond James rating on DYN
- Aug 25, 2025
- Jun 11, 2025
- Feb 27, 2023
- Jul 12, 2022
How other firms rate DYN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Oppenheimer | Perform | $15 | Oct 28, 2026 |
| Cantor Fitzgerald | Overweight | Jul 23, 2026 | |
| TD Cowen | Buy | Jun 26, 2026 |
Questions about Raymond James and DYN
- What is Raymond James's price target for DYN?
- Raymond James's latest stated price target for Dyne Therapeutics Inc. (DYN) is $35, from its action on Aug 25, 2025.
- What is Raymond James's rating on DYN?
- Raymond James rates DYN Strong Buy, a bullish rating, as of Aug 25, 2025.
- When did Raymond James last change its view on DYN?
- On Aug 25, 2025, Raymond James upgrades to Strong Buy from Outperform, price target $35.
More DYN rating histories
All Raymond James ratingsDYN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.